Advanced Prostate Cancer VL

Management of ADT Metabolic Complications: Assessment, Monitoring, Interventions Presentation - Neal Shore

Details
Neal Shore presents on the metabolic complications of androgen deprivation therapy and how to manage them at the Advanced Prostate Cancer Consensus Conference (APCCC 2019). Biography: Neal Shore, MD , Medical Director for the Carolina Urologic Research Center, Myrtle Beach, South Carolina, USA. Related Content: APCCC 2019: Management of Metabolic Changes Download Presentation Slides Read the Full...

The Future of Advanced Prostate Cancer Management: Access to Treatments Presentation - Karim Fizazi

Details
Karim Fizazi presented on global access to treatment of advanced prostate cancer at the Advanced Prostate Cancer Consensus Conference (APCCC 2019). He includes data on current access to radiotherapy on a worldwide level, the use of generic drugs, including docetaxel, abiraterone, and cabazitaxel expected to start in 2021. Lastly, he highlights the use of surgical castration vs. the use of LHRH ago...

The Future of Advanced Prostate Management Presentation - Mark Rubin

Details
Mark Rubin presents on the future of metastatic prostate cancer in regards to biomarkers at the Advanced Prostate Cancer Consensus Conference (APCCC 2019). He discusses both predictive and prognostic biomarkers, currently used biomarker tests, and a summary of some of the many studied biomarkers that are ready and appear promising. In conclusion he shares his beliefs of what we now require which a...

The Future of APC Management in Polymetastatic Disease Presentation - William Oh

Details
In the last 10 years, there has been tremendous progress in the available treatment options for metastatic prostate cancer patients. In this presentation from William Oh at the 2019 Advanced Prostate Cancer Consensus Conference he highlights available treatment options for metastatic prostate cancer patients including serial systemic therapy with combinations of ADT with chemotherapy, abiraterone,...

The Neuroendocrine Prostate Cancer Spectrum Diagnosis and Treatment Presentation - Eleni Efstathiou

Details
Eleni Efstathiou presents an overview of neuroendocrine prostate cancer during the Management of Castration-Resistant Prostate Cancer (CRPC) session at the Advanced Prostate Cancer Consensus Conference (APCCC 2019). Dr. Efstathiou touches on the inaccuracies in the terminology of neuroendocrine prostate cancer, the current state of aggressive variant prostate cancer, where efforts are in place to...

Which Systemic Therapy for Which Patient with Newly Diagnosed Metastatic Prostate Cancer Presentation - Chris Sweeney

Details
Christopher Sweeney presents on systemic therapy for prostate cancer at the Advanced Prostate Cancer Consensus Conference (APCCC 2019). The spectrum of patients starting androgen deprivation therapy (ADT) for metastatic disease is quite vast. Discussing several treatments and several studies as well as their overall survival treatment benefit Dr. Sweeney focuses on which systemic therapy for which...

Sinai Researchers Find First Mechanistic Link between World Trade Center Dust & Prostate Cancer - William Oh

Details
William Oh highlights the first study of people who were exposed to the World Trade Center dust and who subsequently developed prostate cancer. World Trade Center responders with prostate cancer showed signs that inflammation was activated in the prostate after exposure to dust from the World Trade Center site, possibly causing chronic inflammation that contributed to their cancer, according to a...

Looking Into the Future: Oligometastatic Disease Presentation - Misha Beltran

Details
During the 2019 Advanced Prostate Cancer Consensus Conference (APCCC) Himisha Beltran presented an overview looking into the future of oligometastatic disease, and where she predicts we will be in two years’ time. Her presentation focused on refined clinical definitions for disease stratification, nominated molecular biomarkers to capture biologic disease states and defined goals of care for impro...

Movember Session: Outcomes Research – IRONMAN Project - Alicia Morgans and Ian Davis

Details
Alicia Morgans and Ian Davis presented an update on the IRONMAN study, an International Registry for Men with Advanced Prostate Cancer at the Advanced Prostate Cancer Consensus Conference (APCCC). The ultimate goal of this project is to provide the most elaborate description and understanding of patients with advanced prostate cancer. The project includes a description of treatment changes, advers...

How to Treat Men with Newly Diagnosed cN1 cM0 Prostate Cancer: Surgery Options Presentation - Declan Murphy

Details
Declan Murphy presented on node-positive prostate cancer focusing on the staging of high-risk/locally advanced prostate cancer session on Node-positive Prostate Cancer (N1 but M0), How to Treat Men with Newly Diagnosed cN1 cM0 at the Advanced Prostate Cancer Consensus Conference (APCCC) 2019. He elaborates on the performance of conventional imaging for staging clinical node status and the evidence...
email news signup